Implementation

• Do not confuse Toradol (ketorolac) with Torecan (thiethylperazine) or tramadol (Ultram)

» Administration in higher-than-recommended doses does not provide increased effectiveness but may cause increased side effects. Duration of ketorolac therapy, by all routes combined, should not exceed 5 days Use lowest effective dose for shortest period of time

» Coadministration with opioid analgesics may have additive analgesic effects and may permit lower opioid doses

• PO: Ketorolac therapy should always be given initially by the IM or IV route. Use oral therapy only as a continuation of parenteral therapy

• Direct IV:
Administer undiluted. Concentration: 15–30 mg/ml.

• Rate:
Administer over at least 15 sec

• Syringe Compatibility:

» sufentanil

• Syringe Incompatibility:

» haloperidol

» hydroxyzine

» nalbuphine

» prochlorperazine

» promethazine

» thiethylperazine

• Y-Site Compatibility:

» cisatracurium

» dexmedetomidine

» fentanyl

» hydromorphone

» methadone

» morphine

» remifentanil

» sufentanil

• Y-Site Incompatibility:

» azithromycin

» fenoldopam

• Solution Compatibility:

» D5/0.9% NaCl

» D5W

» Ringer's injection

» lactated Ringer's injection

» 0.9% NaCl

ketorolac is a sample topic found in Davis's Drug Guide. All other sections of this record are viewable by clicking on the index in the left column, or by clicking on "Display all Sections" in the "Content Manager".

To find other Davis's Drug Guide topics, please login or purchase a subscription.